EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 24 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $59,000 | +73.5% | 131,050 | +944.0% | 0.00% | 0.0% |
| Q1 2016 | $34,000 | -66.3% | 12,553 | -61.8% | 0.00% | -50.0% |
| Q4 2015 | $101,000 | +87.0% | 32,841 | +167.5% | 0.00% | +100.0% |
| Q3 2015 | $54,000 | -50.5% | 12,279 | +0.6% | 0.00% | -50.0% |
| Q1 2015 | $109,000 | -29.2% | 12,206 | -44.0% | 0.00% | -33.3% |
| Q3 2014 | $154,000 | – | 21,785 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|